Inebilizumab, a B-cell depleting therapy, significantly reduces the risk of flares and increases the likelihood of sustained remission in patients with IgG4-related disease, according to a study. The Phase 3, multicenter, randomized, double-blind,...

Integrating rapid genome sequencing and the BeginNGS platform into newborn screening shows potential for early detection of severe genetic disorders, but there remains a significant challenge in ensuring that parents fully understand the...

While sponsored genetic testing panels improve access to molecular diagnosis for inherited retinal diseases (IRD), significant challenges remain, including varying positivity rates between providers, discrepancies in variant classification (especially for variants of unknown...